The Intelligence layer for Drug Manufacturing
Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
Founder
Founder CSO at Abinitio Bio (YC P26). Biochemist with 14 years of experience, Stanford PhD, former research scientist at the The Broad Institute of Harvard and MIT
